Article (Scientific journals)
Biosafety of Herpesvirus Vectors
Gogev, S.; Schynts, F.; Meurens, F. et al.
2003In Current Gene Therapy, 3 (6), p. 597-611
Peer Reviewed verified by ORBi
 

Files


Full Text
218pub_thiry.pdf
Author postprint (1.8 MB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Abstract :
[en] Herpesviruses are large DNA viruses, which possess a number of advantages as gene delivery vectors. These relate to an ability to package large DNA insertions and establish lifelong latent infections in which the viral genome exists as a stable episome in the nucleus. For gene therapy to become a potential future treatment option, biosafe therapeutically efficient gene transfer is a central, but more and more stringent requirement. This review highlights the progress in development of herpesvirus based vectors, describes their properties as wall as discusses the biosafety concerns that are associated with their use in gene therapy. Thought was also given to biosafety issues pertaining to design and production of herpesvirus vector systems in therapeutic gene delivery.
Disciplines :
Microbiology
Veterinary medicine & animal health
Author, co-author :
Gogev, S.
Schynts, F.
Meurens, F.
Bourgot, I.
Thiry, Etienne ;  Université de Liège - ULiège > Département des maladies infectieuses et parasitaires > Virologie, épidémiologie et pathologie des maladies virales
Language :
English
Title :
Biosafety of Herpesvirus Vectors
Publication date :
December 2003
Journal title :
Current Gene Therapy
ISSN :
1566-5232
Publisher :
Bentham Science Publishers, United Arab Emirates
Volume :
3
Issue :
6
Pages :
597-611
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 04 March 2009

Statistics


Number of views
58 (3 by ULiège)
Number of downloads
0 (0 by ULiège)

Scopus citations®
 
10
Scopus citations®
without self-citations
8
OpenCitations
 
8

Bibliography


Similar publications



Contact ORBi